The aim of the study was to assess the existence of possible associations among frequent polymorphisms in angiotensinogen genes and some of the risk factors for essential hypertension, especially body mass index (BMI) and smoking. A total of 192 control subjects (aged 45.87 ± 3.0 years) and 206 patients with the essential hypertension (aged 48.71 ± 8.42 years) were compared at three angiotensinogen gene polymorphisms by considering BMI and smoking status. No significant differences in genotype and/or allelic distribution for either A (-6) G ATG, M235T or T174M polymorphisms between the hypertensive and control groups were proved. Significantly more hypertensives than control persons with BMI above 25 kg/m 2 were observed (P corr = 0.009), independently on sex distribution. A percentage of 44.6% of smokers in the control group vs 46.0% of smokers in the hypertensive groups were found. No significant dif-
Introduction
The angiotensinogen gene is considered to be one of the classical candidate genes for essential hypertension. In the last two decades, many case-control studies on several frequent angiotensinogen gene polymorphisms were published, often with controversial results. [1] [2] [3] [4] [5] [6] [7] [8] The aim of the study was to assess the existence of possible associations among frequent polymorphisms in the angiotensinogen gene by considering some risk factors of essential hypertension such as BMI and smoking. 
Patients and methods

Subjects
A 'case-control' (essential hypertensive-control subjects) approach was chosen. A sample of the general population of Brno, Czech Republic, was examined by means of monitoring 24-h blood pressure (ABPM, SpaceLab 90207, Wokingham, UK). The sample included complete age-based cohorts from one general practitioner's area (men of 40-45, women of 45-50 years of age) without any previous diagnosis of essential hypertension. From these subjects, 192 controls were recruited according to criterion of the pressure overload with less than 20% blood pressure readings above 140/90 mm Hg during daytime (6.00-22.00), and less than 20% blood pressure readings above 120/80 mm Hg during the night-time (22.00-6.00 the following day). 9 The study included 398 subjects, 192 controls and 206 patients with essential hypertension (Grade 1 and Patients with secondary hypertension and/or diabetes mellitus were not included in the study.
Risk factors
Body mass index (BMI) above 25 kg/m 2 as well as smoking status (smoker/non-smoker) were chosen as sufficiently robust risk factors for association with gene polymorphisms.
The study was approved by the Committee for Ethics of Medical Experiment on Human Subjects, Faculty of Medicine, Masaryk University, Brno (no. 64/93, 1993). The signed, informed consent of the examined subjects was obtained.
Genotype identification
Genomic DNA was isolated from peripheral leukocytes by a standard technique using Proteinase K according to Sambrook. 11 Polymorphism M235T in the angiotensinogen gene (AGT) (1q41-42, exon 2) was detected by the method according to Russ et al 12 (mismatch polymerase chain reaction (PCR), restriction analysis using Asp I, strip lengths of 165, 141 and 24 bp on gel electrophoresis with ethidium bromide, genotypes being marked as MM-165 bp, MT-165+141 bp, TT-141 bp).
Polymorphism A (-6) G AGT was analysed according to Hegele et al. 13 Digestion of a PCR product (65 bp) containing the -6A variant with Bst NI produced two fragments with lengths of 45 and 20 bp. Digestion of a PCR product containing the -6G variant with BstNI produced only a single 65-bp fragment. Digested PCR products were electrophoresed in 3.5% MetaPhore agarose gels and were visualized under UV light after staining with ethidium bromide.
Polymorphism T174M in angiotensinogen gene was detected by our method (mismatch PCR, restriction analysis with NIaIII, bands 116, 95 and 21 bp on gel electrophoresis with ethidium bromide, genotypes described as CC-116 bp, CT0-116+95 bp and TT-95 bp).
Statistics
Differences between groups in allelic frequencies as well as in genotype incidence were calculated using Fisher's exact test. Holm's test was used when appropriate to prevent the problem of multiple comparisons. P-values corrected by Holm's test are presented as P corr .
The differences in genotype distributions as well as Hardy-Weinberg disequilibria for each polymorphism separately were tested using 2 test. The program package Statistica v. 3.0 (Statsoft Inc, Tulsa, and USA) was used.
Results
Significantly more hypertensives than control persons had BMI above 25 kg/m 2 (overweight) (P corr = 0.009), independently on sex distribution. BMI above 30 kg/m 2 was found in 6.9% of controls and in 29.1% of hypertensives. In the control group, 44.6% of smokers vs 46.0% of smokers in the hypertensive group were observed. There were significantly less smokers among hypertensive women compared with hypertensive men (P corr = 0.014). There were no significant differences in concurrence of BMI above 25 kg/m 2 and positive smoking status between control and hypertensives subjects (Table  1) . Genotype distributions of M235T, T174M and (-6) G ATG polymorphisms can be seen in Tables 2,  3 and 4. No significant case-control differences in allelic distribution for either A (-6) G ATG or M235T or T174M polymorphisms were found. The genotypes were found to be in Hardy-Weinberg equilibrium.
14 In more detailed analyses, hypertensive subjects with AA and/ or AG genotypes of A (-6) G ATG polymorphism were more often obese compared with the control group (OR 1.87, 95% CI = 1.6-3.02, P corr = 0.0002). Similarly, hypertensive subjects with CC and/or CT genotypes of T174M ATG were more often in the group with BMI Ͼ25 kg/m 2 than control subjects (OR 1.17, 95% CI 0.78-1.76, P corr = 0.01) and again, hypertensive subjects with MT and/or TT genotypes of M235T ATG had more often BMI Ͼ25 kg/m 2 than control subjects (OR 1.17, 95% CI 0.83-1.65, P corr = 0.01) ( Table 5 ).
Discussion
Most of the regulation of the angiotensinogen gene occurs at the transcriptional level. The two-fold increase of angiotensinogen mRNA expression in adipose tissue was found in obese subjects. 15 BMI as a method reflecting obesity was significantly correlated with the expression of angiotensinogen in visceral adipose tissue. 16, 17 Circulating angiotensinogen levels were related to adipose mass in young, normotensive and non-obese men. 18 Higher plasma levels were found in hypertensive obese patients with increased BMI. 19 The facts suggest the possibility that angiotensinogen may be involved in the plurimetabolic syndrome of visceral obesity.
The G to A substitution located at position -6 upstream of the initial transcription site was described to be of the same frequency and in almost complete linkage disequilibrium with T235 allele the Caucasian, Japanese and Afro Carribean populations, [20] [21] [22] which was confirmed (for Caucasians) by our group. 14 
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Rodriguez-Perez et al 23 refer similar results to ours in allelic and/or genotype differences in two angiotensinogen polymorphisms between normotensives and hypertensives (even with similar numbers of study participants) but with no association with BMI and smoking. Cooper et al 24 did not found a similar association of ATG genotype (M235T) in obese hypertensive population when obesity is defined as BMI above 31 kg/m 2 . Our results do not change substantially after recalculation according to the algorithm and thus stay dissimilar in ethnically different populations.
Differences in genotype distributions and/or allelic frequencies in candidate gene polymorphisms in the essential hypertension-control study could be modulated by a different distribution of risk factors for essential hypertension such as BMI. So far, the possible in vivo contribution of ATG polymorphisms to overweight has not been confirmed. But, despite the statistical nature of the genotype-phenotype associations their founding could contribute to explain the differences in the case-control study results among different research groups.
